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Yeast can use a wide variety of nitrogen compounds. However, the ability to synthesize enzymes and permeases for catabolism of
poor nitrogen sources is limited in the presence of a rich one. This general mechanism of transcriptional control is called nitrogen
catabolite repression. Poor nitrogen sources, such as leucine, 𝛾-aminobutyric acid (GABA), and allantoin, enable growth after the
synthesis of pathway-specific catabolic enzymes and permeases.This synthesis occurs only under conditions of nitrogen limitation
and in the presence of a pathway-specific signal. In this work we studied the temporal order in the induction ofAGP1, BAP2, UGA4,
andDAL7, genes that are involved in the catabolism and use of leucine, GABA, and allantoin, three poor nitrogen sources.We found
that when these amino acids are available, cells will express AGP1 and BAP2 in the first place, then DAL7, and at last UGA4. Dal81,
a general positive regulator of genes involved in nitrogen utilization related to the metabolisms of GABA, leucine, and allantoin,
plays a central role in this coordinated regulation.
1. Introduction
Yeast cells can use a variety of compounds as nitrogen source
through different specific pathways. Synthesis of proteins
involved in each of these pathways is tightly regulated. The
availability of readily transported and metabolized nitrogen
sources, which are known as good nitrogen sources, results
in the strong repression of genes involved in transport and
metabolism of poor ones [1, 2]. The utilization of poor
sources such as leucine and other branched amino acids, 𝛾-
aminobutyric acid (GABA), and allantoin requires the syn-
thesis of pathway-specific catabolic enzymes and permeases.
This synthesis occurs only under conditions of nitrogen
limitation and in the presence of a pathway-specific signal
such as a substrate or an intermediate of a metabolic pathway
[3].
Extracellular GABA is imported into Saccharomyces cere-
visiae cells through three proteins: the general amino acid
permease (Gap1), the proline specific permease (Put4), and
the GABA permease (Uga4) [4]. Within the cells, GABA
is catabolized by the GABA transaminase and succinate
semialdehyde dehydrogenase enzymes encoded by UGA1
and UGA2 genes, respectively [5]. The induction of UGA
genes by GABA requires at least two positive regulatory
proteins: the specific Uga3 factor and the pleiotropic Dal81
factor (also called Uga35) that act through a 19 bp CG-
rich Upstream Activating Sequence named UASGABA [6–
8]. The UASGABA present in UGA4 and UGA1 promoters
contains two independent Uga3 binding sites that consist of
the asymmetric sequence 5󸀠-SGCGGNWTT-3󸀠 (S = G or C,
W = A or T, and N = no nucleotide or G) whereas UGA2
promoter contains only one site [9, 10]. Both factors Uga3 and
Dal81 interact in vivo with the UGA4 promoter in a GABA-
dependent manner [11].
Leucine is a major amino acid in nutrients and proteins.
Its uptake is mediated by multiple amino acid permeases,
including the high-affinity leucine permeases Bap2 and Bap3
and the high capacity permease Agp1. When leucine is
available in the environment, the SPS (Ssy1, Ptr3, and Ssy5)
sensor is activated and hence the transcriptional induction
mediated by the homologous transcription factors Stp1 and
Stp2 takes place.These factors bind to the sequence known as
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Table 1: Strains used in this work.
Strain Genotype Parent Primer Source or reference
Σ1278b Mat𝛼 — — [12]
23344c Mat𝛼 ura3 — — Grenson et al. [4]
SBCY10 Mat𝛼 ura3 6HA-DAL81 — — [11]
SBCY17 Mat𝛼 ura3 dal81Δ::natMX4 — — [11]
SBCY20 Mat𝛼 ura3 uga35::natMX4 leu3::KanMX4 — [11]
MPY09 Mat𝛼 ura3 leu3::loxP 23344c This study
DEBY01 Mat𝛼 ura3 STP1-3HA-KanMX6 23344c This study
DEBY02 Mat𝛼 ura3 dal81Δ::natMX4 STP1-3HA-KanMX6 SBCY17 This study
UASaa first identified in the BAP3 promoter [13] and then in
the BAP2 promoter [14] but later also found in the promoter
sequences of several amino acid permease genes including
AGP1 [15]. In the absence of amino acids, Stp1 and Stp2
are present mainly in the cytoplasm. When amino acids are
detected in the environment, 10 kDa of the N terminus of
these transcription factors is endoproteolytically cleaved off,
resulting in their relocation to the nucleus [16]. Then, Stp1
and Stp2 can act on AGP1 and BAP2 promoters. Dal81 acts
through theUAS sequence facilitating the binding of Stp1 and
Stp2 to AGP1 promoter [17, 18]. It was proposed that Dal81 is
also essential for the induction of BAP2 [19] and that Leu3
modifies the expression of BAP2 [14].
Allantoin, the heterocyclic compound produced during
purine degradation, is rich in nitrogen, and S. cerevisiae
among many other organisms is able to degrade it and
recycle it in order to use it as nitrogen source. The allantoin
degradation pathway converts allantoin to ammonia and car-
bon dioxide. Conversion of allantoin to ammonia is carried
out by the DAL1, DAL2, and DAL3 gene products, which
work sequentially to generate urea. Urea is then degraded
to ammonia in a two-step process by the Dur1,2 protein,
a multifunctional single enzyme originally thought to be
encoded by two tightly linked genes. DAL7 encodes for an
enzyme recycling the glyoxylate generated during allantoin
degradation. All the enzymes associatedwith allantoin degra-
dation are inducible and repressible. Their production is
contingent on the presence of allophanate, the last interme-
diate in the allantoin-degradative pathway or the gratuitous
inducer, oxaluric acid [20]. The cis-acting element mediating
inducer responsiveness of the allantoin pathway genes is
the dodecanucleotide element 𝑈𝐼𝑆ALL(Upstream Induction
Sequence). The DAL81 and DAL82/DURM gene products
are required for this inducer responsiveness. Dal82 has been
shown to be the𝑈𝐼𝑆ALL DNA-binding protein whose binding
to DNA is independent of inducer. Whereas Dal82 appears
to be a pathway-specific regulatory element, Dal81 functions
more broadly, being required for induced expression of the
UGA (GABA catabolic pathway) and AGP1 (amino acid
uptake) genes as well as those of the allantoin pathway [21].
Dal81 is a general positive regulator of genes involved
in nitrogen utilization related to metabolisms of GABA,
urea, leucine, and allantoin [22, 23]; moreover, Dal81 is
involved in the amino acid SPS sensor pathway [17, 18, 24].
In all these induction processes, Dal81 acts together with an
inducer-specific protein; this specific factor is Uga3 inGABA-
induction of UGA genes [6, 11, 25], Dal82 in allophanate-
induction ofDUR andDAL genes [26–28], and Stp1 in amino
acid induction of amino acid permease genes such as BAP2,
BAP3, and AGP1 [17, 18, 24].
A hierarchy for different inducible processes mediated by
the Dal81 factor has been proposed [24]. Our results showing
that the decrease caused by leucine in the recruitment of HA-
Dal81 to the UGA4 promoter depended on Ssy1 supported
this hypothesis [11]. The aim of this work was to study the
mechanisms that lead to the temporal order in the expression
of genes involved in the use of poor nitrogen sources.
2. Methods
2.1. Strains and Media. The S. cerevisiae strains used in this
study are isogenic to the wild type Σ1278b and are listed in
Table 1.
Cells were grown in minimal medium containing 0.17%
Difco yeast nitrogen base (YNB without amino acids and
ammonium sulfate) with 2% glucose as carbon source and
10mM proline as nitrogen source. The final concentrations
of the inducers GABA, leucine, and oxalurate were 0.1mM,
1.3mM, and 1mM, respectively.
MPY09, DEBY01, and DEBY02 mutant strains were
generated using the PCR-based gene-deletion strategy [29,
30] or modified versions of it [31].
The MPY09 strain (leu3Δ deletion) was generated using
the pUG6 plasmid [32] to amplify the loxP-KanMX-loxP
cassette with primers F-leu3 and R-leu3 (Table 2). After
generating the strain, KanMX cassette was excised by recom-
bination mediated by Cre recombinase (pSH47 plasmid).
DEBY01 and DEBY02 strains were generated using
pFA6a-3HA-KanMX6 plasmid [31] and the F-STP1-HA and
R-STP1-HA primers (Table 2).The correct insertion of the tag
was corroborated by PCR using the F-STP1 int, R-STP1 down,
R-Kan int primers.
All yeast transformations were carried out using the
lithium method [33]. Transformants were selected on rich
medium containing 200 𝜇g/ml G418.
To complement the deficiency in DAL81 gene, cells
were transformed with the pSBC-HA-DAL81 plasmid that
contains the complete DAL81 gene [34].
Journal of Amino Acids 3
Table 2: Primers used in this work.
Primer group and name Sequence (5󸀠 to 3󸀠)
Oligonucleotides for strain construction
F-leu3 TGCAATTATGGAAGGAAGATCAGATTTTGTGGCGACTTCACACAGCTGAAGCTTCGTACGC
R-leu3 GGACTTTAAACCTTGGGATTGAACGCAAATTCATTCATTAAACATAGGCCACTAAGTGGATCTG
F-STP1-HA CAATATTTGAATTTTTACAATGACAACTTTGGGTCACAATTTCGGATCCCCGGGTTAATTAA
R-STP1-HA TTCCAATATGATACCCTTATTTTTATCCCGTGTTATATTTAAGAATTCGAGCTCGTTTAAAC
F-LEU3 prom AGGTGCCGCCTAATTTATCG
R-LEU3 int ACTTCTGCTGACGACATTCC
F-KanMX6 int CATCCTATGGAACTGCCTCG
R-KanMX6 int GATAGATTGTCGCACCTGATTG
F-STP1 int GCACAAGATAATCCTTCGTTCC
R-STP1 down TCGGCTTTCCAATATGATACCC
R-Kan int CTATACCTGAGAAAGCAACCTG
Oligonucleotides for RT-qPCR
F-qRT-UGA4 CTGCTGCTGTCACATTAACC
R-qRT-UGA4 AATACACATAACCACCACTGC
F-qRT-DAL7 AACCGAACAAATCAGGAAC
R-qRT-DAL7 CAAGTTGGAGATGAAGAGTC
F-qRT-BAP2 TAGAGGATGGCGTTGAGTC
R-qRT-BAP2 ACCAAGATGTAACCAATTATTAGC
F-qRT-AGP1 ATCTTATTCCTATTCTTGGCTACC
R-qRT-AGP1 CGGCGTTAATGAAGTGTGG
F-qRT-TBP1 TATAACCCCAAGCGTTTTGC
R-qRT-TBP1 GCCAGCTTTGAGTCATCCTC
Oligonucleotides for ChIP
F-UGA4 GGAACTGATTACTGTGCCAAG
R-UGA4 AATCGCTTATCGCTTATCGTG
F-AGP1 TTATACCTCGGCGGCTTC
R-AGP1 GCAAGATTTCTCCAAAGTCC
F-BAP2 AGGAGGCTACTGACACTGC
R-BAP2 GCTGACATATTTACCGTTGAAGG
F-DAL7 AATCTCCGCTGAAGTTGC
R-DAL7 TTTCACGATGTACCTTATCCAAGA
F-UC AGTCCAATACCTCTGTCCTC
R-UC AGCCGCAACTTCATTCTG
2.2. Quantitative RT-PCR. RT-qPCR experiments were per-
formed according to Cardillo et al. [34]. cDNAs were quanti-
fied by RT-PCR using an Opticon Monitor 3 (Bio-Rad) with
the primers listed in Table 2. Expression values correspond to
the ratio of concentrations of UGA4, AGP1, BAP2, and DAL7
over TBP1 specific mRNAs determined in each sample and
represent themean± SEMof three independent experiments.
2.3. Chromatin Immunoprecipitation Assays. Chromatin
immunoprecipitation (ChIP) experiments were performed
according to Cardillo et al. [25]. Normal mouse IgG (Santa
Cruz) or monoclonal anti-HA antibody (HA probe (F-7),
Santa Cruz) was used. Real time quantitative PCR was
carried out in an Opticon Monitor 3 (Bio-Rad) with primers
that amplified promoter regions of UGA4, AGP1, DAL7,
and BAP2 genes (Table 2). A pair of primers that amplified
a region located 2.5 Kb downstream of UGA4 promoter
(F-UC/R-UC) was used as an unbound control. ChIP DNA
was normalized to input DNA and calculated as a signal-to-
noise ratio over IgG control ChIP. The ΔΔCt method was
used to calculate fold change of binding to the promoter of
interest [35]. Results are expressed as the mean ± SEM of
three independent experiments.
3. Results and Discussion
It has been proposed that the expression of genes that encode
permeases of different poor nitrogen sources follows a certain
order rather than occurring simultaneously.
In order to determine this hierarchy, we measured the
induction of each gene in the presence of the inducer
of another gene. For instance, to analyze the effect of
the inducers of DAL7, AGP1, and BAP2 genes on GABA-
induction ofUGA4, exponentially grown cells were incubated
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Figure 1: Effect of Dal81 on gene induction. mRNA levels of UGA4 (a), DAL7 (b), AGP1 (c), and BAP2 (d) were determined in wild type
cells (23344c strain), dal81Δ cells (SBCY17 strain), and dal81Δ cells transformed with the pSBC-HA-DAL81 plasmid. The second inducer,
the specific one, was added 30 minutes after the addition of the first one and cells were incubated for another 30 minutes. mRNA levels
were quantified by RT-qPCR. UGA4, DAL7, AGP1, and BAP2 values were normalized with TBP1 and results are the mean ± SEM of three
independent experiments. Within each strain the values measured were normalized to the value obtained for the uninduced condition.
for 30 minutes with oxalurate or leucine before the 30-
minute incubation with GABA. The induction of UGA4
produced by the presence of GABA was strongly inhibited
by leucine, the inducer of AGP1 and BAP2 genes, and also
by oxalurate, the inducer of DAL7 (Figure 1(a)). This is
indicating that GABA is incorporated into the cells for its
catabolism only after the leucine and allantoin added to
the culture medium are used. The induction of DAL7 by
oxalurate was significantly lower when cells were previously
incubated by leucine while preincubation with GABA did
not produce any effect (Figure 1(b)), suggesting that the use
of allantoin might occur in the presence of GABA but only
after the consumption of leucine.The expression ofAGP1 and
BAP2 genes was induced by leucine and it was not affected
by GABA or oxalurate (Figures 1(c) and 1(d)). These results
suggest that the order of the use of the analyzed poor nitrogen
sources could be leucine, allantoin, and then GABA.
As expected, the induction ofUGA4,DAL7, and AGP1 by
GABA, oxalurate, and leucine, respectively, strictly depended
on the activity of the transcription factor Dal81 since no
induction was detected in dal81Δ cells (Figures 1(a), 1(b), and
1(c)). On the other hand, the induction of BAP2 measured
in dal81Δ cells was significantly lower than that observed in
wild type cells although some induction was still detected
(Figure 1(d)). Our results suggest that although Dal81 is
involved in BAP2 transcription as it was reported earlier [19],
it is not essential for this process. Both BAP2 and AGP1 are
regulated by the pair of transcription factors Dal81 and Stp1;
however the role of Dal81 on the regulation of each gene
seems to be different.
The fact that Dal81 is involved in these induction pro-
cesses makes this factor a good candidate as the protein that
establishes the hierarchy. So, this hierarchy might be due to
the recruitment of Dal81 in the firstly induced genes with
the consequently lower availability of this transcription factor
to act on the other promoters. To test this hypothesis, we
measured the induction of each gene in the presence of the
inducers of other genes in cells that overexpressed Dal81. For
this purpose, dal81Δ cells were transformed with the pSBC-
HA-DAL81 plasmid [34] that contains the complete DAL81
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Figure 2: Interaction of Dal81 with UGA4, AGP1, and DAL7 promoters. Wild type cells, expressing the HA-Dal81 (SBCY10 strain) fusion
protein, were treated or not with the indicated inducers. ChIP assays were carried out using antibodies against the HA epitope. qPCR was
performed with specific primers (black bars) that amplify a region of UGA4 promoter (a), a region of AGP1 promoter (b), a region of DAL7
promoter (c), and a region 2.5 kb downstream of UGA4 promoter used as a negative control (white bars). Results are expressed as the fold
change of binding to the promoter of interest and are the mean ± SEM of three independent experiments.
open reading frame under the control of the GPD1 promoter.
When the expression of DAL81 was under the regulation of
the strong and constitutive promoter GPD1, the induction of
UGA4 by GABA was not inhibited by the presence of leucine
nor oxalurate and the induction ofDAL7 by oxalurate was not
inhibited by the presence of leucine (Figures 1(a) and 1(b)). So,
this finding confirms our hypothesis since when Dal81 is not
a limiting factor, the hierarchy is not observed.
Thenwe analyzed the binding that occurs in vivo between
Dal81 and UGA4, AGP1, and DAL7 promoters. We found
that the strong binding of Dal81 with the regulatory region
of UGA4 detected after incubating the cells with GABA
significantly weakenedwhen the cells were preincubatedwith
leucine (Figure 2(a)). This inhibition by leucine was earlier
shown [11]. In the contrary, the amount of Dal81 bound to
the promoter of AGP1 did not change after the preincubation
with GABA (Figure 2(b)). These results reinforce our idea of
Dal81 being the limiting factor in these induction processes.
On the other hand, we did not find any effect of leucine on
the oxalurate-dependent binding of Dal81 toDAL7 promoter
(Figure 2(c)). However, it must be noticed that the binding
measured after the incubation with oxalurate was already
very weak. So, we think that this result is probably due to
technical difficulties in these ChIP assays.
We were not able to detect Dal81 bound to the regulatory
region of BAP2 gene (data not shown). This suggests that the
mild effect of Dal81 detected on BAP2 (Figure 1(d)) is not due
to a direct interaction. Again, Dal81 acts in a different way on
BAP2 compared to onAGP1 in contrast with previous reports
[18]. To assess this, we measured the binding of Stp1 to AGP1
and BAP2 genes. We found that Stp1 strongly bound to AGP1
promoter after the incubation with the inducer leucine and
this interaction was avoided in a dal81Δ strain (Figure 3(a)).
This result is in agreement with those obtained by Boban
and Ljungdahl [17]. Stp1 also bound to BAP2 promoter in
a leucine dependent manner (Figure 3(b)). However, it was
rather surprising to find that this interaction also depended
on the presence of Dal81. As Dal81 did not seem to bind
to BAP2, the mechanism by which it facilitates Stp1 binding
to this gene might be indirect, probably through Leu3. The
expression of BAP2 gene was significantly higher in leu3Δ
cells, indicating that in our growth conditions Leu3 factor
has a negative effect on BAP2 (Figure 3(d)). It was earlier
reported that the Leu3 binding site in the BAP2 promoter
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Figure 3: Role of Dal81 in AGP1 and BAP2 regulation. Wild type cells, expressing the Stp1-HA (DEBY01 strain) fusion protein, were treated
or not with leucine. ChIP assays were carried out using antibodies against the HA epitope. qPCR was performed with specific primers (black
bars) that amplify a region of AGP1 promoter (a), a region of BAP2 promoter (b), and a region 2.5 kb downstream of UGA4 promoter (white
bars) used as a negative control. Results are expressed as the fold change of binding to the promoter of interest and are themean± SEMof three
independent experiments. mRNA levels of AGP1 (c) and BAP2 (d) were determined in wild type cells (23344c strain), leu3Δ cells (MPY09
strain), and leu3Δ dal81Δ cells (SBCY20 strain).The cells were incubated with or without leucine for 30minutes. mRNA levels were quantified
by RT-qPCR. AGP1 and BAP2 values were normalized with TBP1 and results are the mean ± SEM of three independent experiments.
is required for full promoter activity [14]. This apparent
contradiction is probably due to different growth conditions
since it is known that Leu3 is a transcription factor that can
act as an activator or as a repressor depending on the content
of 𝛼-isopropylmalate within the cells [36]. Different growth
conditions lead to changes in this content. Our results also
reveal a substantial difference in the regulation of AGP1 and
BAP2 sinceAGP1 is not regulated by Leu3. In the leu3Δ dal81Δ
doublemutant the expression ofBAP2was significantly lower
than in the single mutant leu3Δ, confirming that Dal81 is
somehow participating in the expression of BAP2. It must be
noted that we have already found a negative effect of Leu3 on
UGA4 gene, although we were not able to detect Leu3 bound
to this gene [11]. Moreover, De Boer et al. demonstrated that
Leu3 acts as a repressor on BAP3 expression but they also
failed in detecting any interaction [13].
4. Conclusions
In this work we showed that the expression of the proteins
responsible for the uptake and catabolism of different poor
nitrogen sources occurs sequentially following a certain
order determined by a tight regulation. This order could
promote the utilization of a given nitrogen source whereas
the utilization of others, which may be less useful, could be
downregulated in some growthmedia.Wedemonstrated here
that the transcription factor Dal81 is central in the regulation
that leads to the hierarchical expression of the genes studied
here and, consequently, in the utilization of leucine, allantoin,
andGABA.BAP2, the gene of one of the permeases of leucine,
seems not to be included in this hierarchical regulation since
the regulation of BAP2 by Dal81 occurs through an indirect
mechanism. This may have a physiological significance since
Iraqui and collaborators [18] failed to show any contribution
of Bap2 to the utilization of leucine as the sole nitrogen source
andCohen and Engelberg [37] suggested that Bap2 is the only
functional leucine transporter on rich media.
The doubling time of wild type cells in minimal medium-
cultures containing leucine as the sole nitrogen source
was twice that of cultures in minimal medium contain-
ing GABA (http://www.doubling-time.com/compute.php).
Other authors obtained similar values of doubling time of
cells grown on allantoin orGABA as the sole nitrogen sources
[38]. It is commonly assumed that preferred nitrogen sources
allow higher growth rates. This is true when comparing rich
and poor sources. However, if the order of the expression
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of AGP1, DAL7, and UGA4 was determining a hierarchy in
the use of their substrates, that assumption would not be
fulfilled for poor nitrogen sources. Probably, the importance
of leucine as a ketogenic amino acid that supplies energy to
the cells and its high frequency in protein composition led to
a regulation that ends in the use of this poor nitrogen source
before others that provide a higher growth rate.
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